FDA approves Xolair as the first and only medicine for children and adults with one or more food allergies
Roche announced today that the FDA has approved Xolair® (omalizumab) for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one or more foods in adult and paediatric patients aged 1 year and older with…